EN IT

Reserved

PepsiCo: bounce absorbed, the decline reasserts

·45 min read
EXECUTIVE VIEW

PepsiCo weekly technical analysis — week 13 of a sell signal, +5.35% performance from inception. After last week's bounce, selling pressure returned with 83% sell volume. CMF in distribution, MACD deteriorating — the downtrend holds, though the stock shows signs of fatigue in the 140 area.

Reserved analysis Subscribe to read →
Reserved

PG&E Corporation: the rebound fades, the downtrend regains momentum

·45 min read
EXECUTIVE VIEW

PG&E Corporation sell signal at week 12 — the early-June rebound has reversed: the week closed down 2.8% with sellers at 79% and CMF back in strong distribution. Trade setup confirmation suggests exiting the position. Performance since inception: +4%.

Reserved analysis Subscribe to read →
Reserved

Petroleo Brasileiro: the 18 area wall holds, short in profit

·45 min read
EXECUTIVE VIEW

Petroleo Brasileiro SA stock — week 3 sell signal, +10.76% performance since entry. Weekly technical analysis: bearish structure, setup quality index at 69, Energy sector (XLE) down 6.57%. The 18 area wall has rejected price multiple times. Trading not recommended.

Reserved analysis Subscribe to read →
Reserved

Coverage complete, trend intact: PANW's remaining position keeps running

·46 min read
EXECUTIVE VIEW

Palo Alto Networks week 14 buy setup — +72% performance from entry. All 3 time-window targets of our technical analysis model are past. The residual position continues with a trailing stop on the weekly Inversion Point.

Reserved analysis Subscribe to read →
Reserved

Occidental Petroleum: sell-off accelerates at week 9

·45 min read
EXECUTIVE VIEW

Occidental Petroleum weekly technical analysis — week 9 of a sell setup, with a sharp -8.3% weekly drop and 83% sell volume. Performance at +3.66% from trade inception. The decline has resumed force after a brief pause.

Reserved analysis Subscribe to read →
Reserved

Oscar Health: +96% since entry, all 3 targets hit, stop at breakeven

·46 min read
EXECUTIVE VIEW

Oscar Health week 10 of a buy setup with +96.54% performance since entry. All 3 targets of our most advanced model hit ahead of schedule, stop at breakeven: zero risk, position running free.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn